<DOC>
	<DOCNO>NCT01544517</DOCNO>
	<brief_summary>A five day quadruple concomitant therapy effective safe 10 day sequential therapy eradication H. pylorus infection .</brief_summary>
	<brief_title>5 Day Concomitant Versus 10 Day Sequential Therapy Eradication H. Pylori Infection</brief_title>
	<detailed_description>The investigator study 180 consecutive patient H. pylori infection randomize 5-day concomitant therapy ( 90 patient ) 10-day sequential therapy ( 90 patient ) . 6 10 week end therapy , patient evaluate H. pylorus status 13C Urea Breath Test . Side effect cost either regimen evaluate . In patient whose H pylorus status entry assess endoscopy , culture perform antimicrobial resistance determine</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Tinidazole</mesh_term>
	<criteria>H. pyloriinfected patient least 18 year age never receive H. pylori eradication treatment include study . previous treatment H. pylorus infection , use inhibitor acid secretion and/or antibiotic 6 week study , gastrointestinal malignancy , previous gastrooesophageal surgery , severe concomitant cardiovascular , respiratory endocrine disease , clinically significant renal hepatic disease , hematologic disorder , clinically significant medical condition could increase risk , history allergy drug use study , pregnancy lactation , alcohol abuse , drug addiction , severe neurologic psychiatric disorder , longterm use corticosteroid antiinflammatory drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Concomitant therapy</keyword>
	<keyword>Sequential therapy</keyword>
	<keyword>levofloxacin</keyword>
</DOC>